What is the standard treatment for ependymoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The standard treatment for ependymoma typically involves maximal safe surgical resection followed by radiation therapy, as recommended by the European Association of Neuro-Oncology guidelines 1. Surgery aims to remove as much of the tumor as possible while preserving neurological function, with complete resection being the most important prognostic factor. After surgery, focal radiation therapy (54-59.4 Gy) is usually administered to the tumor bed, particularly for higher-grade tumors or those with incomplete resection. For young children under 3 years, radiation may be delayed to avoid neurocognitive effects, with chemotherapy sometimes used in the interim. Chemotherapy generally plays a limited role in initial treatment but may be considered for recurrent disease, with regimens including platinum agents (cisplatin, carboplatin), cyclophosphamide, etoposide, and vincristine. Some key points to consider in the treatment of ependymoma include:

  • The importance of gross total resection (GTR) in improving outcomes, as noted in studies 1.
  • The use of postoperative radiotherapy to improve local control and survival rates, as shown in studies 1.
  • The limited role of chemotherapy in initial treatment, but its potential use in recurrent disease, as discussed in studies 1.
  • The need for individualized treatment decisions based on tumor location, grade, extent of resection, patient age, and performance status, as emphasized in guidelines 1.
  • The importance of regular follow-up with MRI scans to monitor for recurrence, as ependymomas can recur locally or spread through the cerebrospinal fluid, as noted in studies 1. Treatment decisions should be made on a case-by-case basis, taking into account the specific characteristics of the tumor and the patient's overall health, as recommended by the European Association of Neuro-Oncology guidelines 1.

From the Research

Standard Treatment for Ependymoma

The standard treatment for ependymoma typically involves a combination of therapies, including:

  • Maximal surgical resection to remove as much of the tumor as possible 2, 3
  • Focal radiation therapy, which may be used depending on the presence of residual disease and tumor grade 2, 4
  • Chemotherapy, which may be considered in certain cases, such as for infants to delay radiation or to improve resectability 2, 3

Role of Radiation Therapy

Radiation therapy plays a crucial role in the treatment of ependymoma, with:

  • Conformal radiation therapy (CRT) being used to target the tumor with a high degree of precision 4
  • Stereotactic radiosurgery (SRS) emerging as a potential alternative for recurrent or residual cases 5, 6
  • Radiation therapy being used to improve local tumor control and overall survival rates 4, 5, 6

Factors Influencing Treatment Outcomes

Several factors can influence treatment outcomes for ependymoma, including:

  • Extent of surgical resection, which remains the principal risk factor that clearly influences outcome 3
  • Age, location, grade, and stage of the tumor, which can impact treatment outcomes 4, 3
  • Tumor volume and histology, which can affect local tumor control and progression-free survival rates 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adjuvant treatments for ependymomas.

Journal of neurosurgical sciences, 2018

Research

Ependymoma: an update.

Journal of child neurology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.